Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Body PSOriasis: Long-term Relapse Control in Patients With Psoriasis Vulgaris in Daily Clinical Practice of Russian Dermatologists.

NCT03402828 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT03402828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Body PSOriasis: Long-term Relapse Control in Patients With Psoriasis Vulgaris in Daily Clinical Practice of Russian Dermatologists.
Lead sponsor
LEO Pharma
Phase
Observational
Overall status
Completed
Start date
June 11, 2018
Completion date
May 15, 2020
Enrollment
764 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris